Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer

European Journal of Cancer

Volumn 44, Issue 13, 2008, Pages 1895-1903

  Hartel, Mark ^a,b   Narla, Goutham ^c   Wente, Moritz N ^a   Giese, Nathalia A ^a   Martignoni, Marc E ^a,b   Martignetti, John A ^c   Friess, Helmut ^a,b   Friedman, Scott L ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Kr ppel like factor 6; Pancreatic cancer; Tumour suppressor gene

Indexed keywords

BIOLOGICAL MARKER; KRUPPEL LIKE FACTOR 6; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KLF6 GENE; MALE; PANCREAS CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 49549098364     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.06.030     Document Type: Article

References (36)

1. Bieker J.J. Kruppel-like factors: three fingers in many pies. J Biol Chem 276 (2001) 34355-34358
2. Schuh R., Aicher W., Gaul U., et al. A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene. Cell 47 (1986) 1025-1032
3. Dang D.T., Pevsner J., and Yang V.W. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 32 (2000) 1103-1121
4. Kaczynski J., Cook T., and Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol 4 (2003) 206
5. Turner J., and Crossley M. Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem Sci 24 (1999) 236-240
6. Koritschoner N.P., Bocco J.L., Panzetta-Dutari G.M., Dumur C.I., Flury A., and Patrito L.C. A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem 272 (1997) 9573-9580
7. Ratziu V., Lalazar A., Wong L., et al. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA 95 (1998) 9500-9505
8. Narla G., Heath K.E., Reeves H.L., et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294 (2001) 2563-2566
9. Kim Y., Ratziu V., Choi S.G., et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 273 (1998) 33750-33758
10. Slavin D.A., Koritschoner N.P., Prieto C.C., Lopez-Diaz F.J., Chatton B., and Bocco J.L. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene 23 (2004) 8196-8205
11. Kimmelman A.C., Qiao R.F., Narla G., et al. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6. Oncogene 23 (2004) 5077-5083
12. Benzeno S., Narla G., Allina J., et al. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res 64 (2004) 3885-3891
13. Chen C., Hyytinen E.R., Sun X., et al. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162 (2003) 1349-1354
14. Cho Y.G., Kim C.J., Park C.H., et al. Genetic alterations of the KLF6 gene in gastric cancer. Oncogene 24 (2005) 4588-4590
15. Reeves H.L., Narla G., Ogunbiyi O., et al. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126 (2004) 1090-1103
16. Kremer-Tal S., Reeves H.L., Narla G., et al. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 40 (2004) 1047-1052
17. Difeo A., Narla G., Hirshfeld J., et al. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res 12 (2006) 3730-3739
18. Ito G., Uchiyama M., Kondo M., et al. Kruppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 64 (2004) 3838-3843
19. Glinsky G.V., Glinskii A.B., Stephenson A.J., Hoffman R.M., and Gerald W.L. Gene expression profiling predicts clinical outcome of prostate cancer 2. J Clin Invest 113 (2004) 913-923
20. Narla G., Difeo A., Reeves H.L., et al. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65 (2005) 1213-1222
21. Yea S., Narla G., Zhao X., et al. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma. Gastroenterology 134 (2008) 1521-1531
22. Narla G., Difeo A., Yao S., et al. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread 2. Cancer Res 65 (2005) 5761-5768
23. Schneider G., Siveke J.T., Eckel F., and Schmid R.M. Pancreatic cancer: basic and clinical aspects. Gastroenterology 128 (2005) 1606-1625
24. Garcea G., Neal C.P., Pattenden C.J., Steward W.P., and Berry D.P. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41 (2005) 2213-2236
25. Lockhart A.C., Rothenberg M.L., and Berlin J.D. Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 128 (2005) 1642-1654
26. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
27. Luttges J., Schemm S., Vogel I., Hedderich J., Kremer B., and Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol 191 (2000) 154-161
28. Heinmoller E., Dietmaier W., Zirngibl H., et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 157 (2000) 83-92
29. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg 9 (2002) 76-85
30. Heinmoller E., Bockholt A., Werther M., et al. Laser microdissection of small tissue samples - application to chronic pancreatitis tissues. Pathol Res Pract 199 (2003) 363-371
31. Yamano M., Fujii H., Takagaki T., Kadowaki N., Watanabe H., and Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156 (2000) 2123-2133
32. Kojima S., Hayashi S., Shimokado K., et al. Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood 95 (2000) 1309-1316
33. Wikman H., Kettunen E., Seppanen J.K., et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21 (2002) 5804-5813
34. Yamashita K., Upadhyay S., Osada M., et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2 (2002) 485-495
35. Jeng Y.M., and Hsu H.C. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 105 (2003) 625-629
36. Glinsky G.V., Berezovska O., and Glinskii A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115 (2005) 1503-1521